Literature DB >> 11774299

Adsorption and release properties of growth factors from biodegradable implants.

J Ziegler1, U Mayr-Wohlfart, S Kessler, D Breitig, K-P Günther.   

Abstract

The present investigation was performed to study the adsorption behavior of growth factors and their release characteristics from biodegradable implants in an in vitro study. We investigated the stability of growth factors administered on various scaffolds. We used porous tricalcium phosphate ceramics (alpha-TCP), a neutralized glass-ceramics (GB9N), a composite (polylactid/-glycolid/GB9N), and solvent dehydrated human bone as carriers. Block shaped scaffolds (sized: 7 x 7 x 10 mm) were loaded with 5 microg of either bone morphogenetic protein (rxBMP-4), basic fibroblast growth factor (rh-bFGF), or vascular endothelial growth factor (rh-VEGF) solved in 150 microL PBS. The growth factors were labeled with Iodine125 (I-125) for detecting the adsorbed and released amount of growth factors by counting the samples for total I-125 activity. We observed that the adsorption of these growth factors seems to depend on two different parameters: first on the nature of the tested material, and second on the growth factors on their own. The release kinetics of the growth factors from the biodegradable implants can be described as a two phase process-a very rapid release during the first hours by an elution of not adsorbed protein, followed by a specific release, which depends upon the chemical/physical interaction of the material and the growth factor used. Analyzing the eluted proteins on SDS-PAGEs rh-VEGF was degraded into a smaller fragment with a size of around 15 kDa, while rxBMP-4 and rh-bFGF showed a complete degradation into fragments smaller than 3 kDa after more than 3 days. Although this in vitro study suggests that biodegradable implants might be successfully used as carriers for osteogenic growth factors, the different release kinetics as well as the alteration of their molecular structure including loss of biological activity should be considered. Copyright 2001 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11774299     DOI: 10.1002/jbm.1258

Source DB:  PubMed          Journal:  J Biomed Mater Res        ISSN: 0021-9304


  21 in total

1.  Nano-fibrous scaffold for controlled delivery of recombinant human PDGF-BB.

Authors:  Guobao Wei; Qiming Jin; William V Giannobile; Peter X Ma
Journal:  J Control Release       Date:  2006-03-03       Impact factor: 9.776

Review 2.  Bone tissue engineering therapeutics: controlled drug delivery in three-dimensional scaffolds.

Authors:  Viviana Mouriño; Aldo R Boccaccini
Journal:  J R Soc Interface       Date:  2009-10-28       Impact factor: 4.118

3.  Binding and release characteristics of insulin-like growth factor-1 from a collagen-glycosaminoglycan scaffold.

Authors:  Leanne M Mullen; Serena M Best; Roger A Brooks; Siddhartha Ghose; Jessica H Gwynne; John Wardale; Neil Rushton; Ruth E Cameron
Journal:  Tissue Eng Part C Methods       Date:  2010-05-22       Impact factor: 3.056

4.  Fucoidan in a 3D scaffold interacts with vascular endothelial growth factor and promotes neovascularization in mice.

Authors:  Agung Purnama; Rachida Aid-Launais; Oualid Haddad; Muriel Maire; Diego Mantovani; Didier Letourneur; Hanna Hlawaty; Catherine Le Visage
Journal:  Drug Deliv Transl Res       Date:  2015-04       Impact factor: 4.617

5.  The effect of Emdogain and platelet-derived growth factor on the osteoinductive potential of hydroxyapatite tricalcium phosphate.

Authors:  R C Chan; V Marino; P M Bartold
Journal:  Clin Oral Investig       Date:  2011-10-28       Impact factor: 3.573

6.  Nano-fibrous tissue engineering scaffolds capable of growth factor delivery.

Authors:  Jiang Hu; Peter X Ma
Journal:  Pharm Res       Date:  2011-01-14       Impact factor: 4.200

7.  Healing of localized gingival recessions treated with a coronally advanced flap alone or combined with an enamel matrix derivative and a porcine acellular dermal matrix: a preclinical study.

Authors:  Y Shirakata; A Sculean; Y Shinohara; K Sena; N Takeuchi; D D Bosshardt; K Noguchi
Journal:  Clin Oral Investig       Date:  2015-11-27       Impact factor: 3.573

8.  Nanostructured Biomaterials for Regeneration.

Authors:  Guobao Wei; Peter X Ma
Journal:  Adv Funct Mater       Date:  2008-11-24       Impact factor: 18.808

9.  Polycaprolactone coated porous tricalcium phosphate scaffolds for controlled release of protein for tissue engineering.

Authors:  Weichang Xue; Amit Bandyopadhyay; Susmita Bose
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2009-11       Impact factor: 3.368

10.  Nonviral gene delivery from nonwoven fibrous scaffolds fabricated by interfacial complexation of polyelectrolytes.

Authors:  Shawn H Lim; I-Chien Liao; Kam W Leong
Journal:  Mol Ther       Date:  2006-02-23       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.